Alliance partnerships

Fostering collaboration across the pharmaceutical and drug delivery value chain

Creating value through collaboration

To strengthen our capabilities for fully vertically integrated solutions, we actively build a strong partnership ecosystem across the drug-delivery value chain. We believe that maximizing value for our customers requires close connections within the broader drug delivery ecosystem, enabling us to provide informed advice, clear recommendations, and flexible options at every stage. That’s why we established our Alliance Management program, bringing together trusted partners such as primary container providers, CMOs/CDMOs, and specialized service providers to deliver integrated, end‑to‑end solutions for our customers.
20241029 PDA Aseptic Korea 2024 shl-medical conversation-markus-bauss-2

Customer benefits and partnership categories

Through our partnership network, you gain access to enhanced services and support along the entire device value chain, ensuring smoother processes and better results for your projects.

 

Primary packaging
  • Providing joint expertise and guidance on device-container compatibility
  • De-risking selection of primary container by conducting pre-verification assessment of various containers variants
  • Driving innovation and setting standards for new container formats 
CDMO and CMO
  • Supporting partner C(D)MOs across the globe in establishing final assembly service and pre-validating their final assembly equipment for SHL platform devices
  • Introducing fill-finish services for new container formats to ensure speed-to-market for novel SHL devices
  • Providing joint expertise and guidance on fill-finish and final assembly
Patient education
  • Developing standard trainers for SHL platform devices to reduce the overall trainer development timeline
  • Offering a broad range of services to support patient engagement and adherence: IFU and packaging development, human factors and UX support services, patient training videos, on-boarding kits
Consulting
  • Providing joint expert advice and guidance along the drug and device development journey
  • Establishing efficient collaboration and communication pathways to streamline joint customer projects
[.jpg] shl-medical-pda-miniverse-usa-11-Edit

Thought leadership

We are proud to collaborate with innovators and key suppliers to pharma, ensuring that our customers receive the best possible support. Read on to learn more about some of our recent partner collaborations.

More Than the Sum of Its Parts: How Supplier Collaboration Drives Successful Combination Products - Download

Discover how the collaboration between SHL Medical, Gerresheimer, and Aptar Pharma supports the successful development of patient-centric combination products.

 

Download the document

Proving the Design Space: Advancing the Development of Syringe-Device Combinations - Download

Explore how SHL Medical and Stevanato Group are mitigating integration risks and accelerating time to market through strategic collaboration.

 

Download the document

Exploring Platform Synergies: Enabling High-Viscosity Biologic Delivery with SHL Medical's Molly® 2.25 mL Autoinjector and Stevanato Group’s Syringes - Download

Learn how cross-platform integration through the combination of Stevanato Group’s portfolio of syringes and SHL’s Molly® autoinjector broadens the platform design space for high-volume, high-viscosity biologics.

 

Download the document

Want to partner with us?

Join our growing Alliance network and help shape the future of drug delivery through collaboration, innovation, and shared success.

Call us

Mon-Fri from 8:00AM-5:00PM (GMT+2)
+41 41 368 00 00

Visit us

You can find our office HQ at
Gubelstrasse 22
6300 Zug, Switzerland